One in five Americans report ever taking a GLP-1 for weight loss or a chronic condition, according to a 2025 poll
Most doctors recommend that candidates have already tried other weight management approaches, including dietary changes and increased physical activity
In univariable and multivariable analyses, age, race, ethnicity, baseline BMI, diabetes diagnosis, breast cancer stage, histology, breast cancer subtype, and menopausal status were not significantly associated with having 5% or greater weight loss at 12 months after GLP-1 RA initiation ( Figure )
The only similarity is that both are sub-therapeutic doses meant to prepare your body for higher amounts
Enter BPC-157 (Body Protection Compound-157), a pentapeptide derived from gastric juice that's showing extraordinary promise in accelerating tissue repair at the cellular level